全球药物发现信息市场根据Polaris市场研究的一项新的研究，预计大小将达到2028美元的5.62亿美元。betway苹果下载那个报告 ”Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow (Discovery Informatics, Development Informatics); By Mode (Outsourced, In-house); By Services (Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management, Others); By Regions; Segment Forecast, 2021 – 2028“详细了解当前市场动态，并提供未来市场增长分析。
在2020年，序列分析市场分部占最大份额，并且可能会在研究期间注册大量的市场增长。对于序列分析，生物信息学工具起着重要作用。它们广泛用于开发蛋白质，核酸和其他生物分子序列的专有数据库。随着信息学解决方案的上升，基因测序是通过鉴定蛋白质和基因进行的，这可以进一步帮助潜在药物的发展。
Basic drug discovery requires the involvement of different sets of databases, sequence analysis tools, such as BLAST, FASTA, and CLUSTALW. Moreover, the introduction of new products and software tools with higher computing capabilities are further contributing to the segment’s market growth. In this line, in July 2019, Certara introduced its new version of D360, a drug discovery platform. The platform enabled analysis, representation, alignment of the small sections of peptides.
分子建模市场部门预计在研究期间见证了利润丰厚的市场增长。由于其在药物发现过程中的广泛适用性，该技术是受欢迎的。这些工具主要用于模拟小分子以预测其在分子水平时的行为。此外，该技术还能够在药物发现过程中加速成本效率。
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below://m.jiayuancx.com/industry-analysis/drug-discovery-informatics-market/request-for-sample
Moreover, accelerated COVID-19 drug discovery programs across the globe are further favoring the market growth. It helps in providing fast-track services, where scientists could perform virtual screening via drug from DrugBank, to target viral proteins and human ACE2 receptors. Such studies were also based on the in-silico tools to screen small molecules which have the potential to counter COVID-19.
Similarly, companies in the marketplace are introducing services supporting or speeding up the drug development process. In this line, in June 2020, IBM visual molecular explorer platform was used to segregate a set of molecules targeting COVID-19. This is the open-source sharable AI-enabled platform involved in the initial screening of potential drug candidates.
业内市场参与者包括Certara，Infosys Ltd.，奥尔巴尼分子研究公司，查尔斯河实验室，Boehringer Ingelheim，合作药物发现，喜庆Biosys，Selvita，Novo信息学，Eurofins Discoverx产品，Chemaxon Ltd.，Oracle，Eccenture，AgilentTechnologies，Inc。和Illumina，Inc。
Polaris Market Research has segmented the drug discovery informatics market report on the basis of workflow, mode, Services, and region:
Drug Discovery Informatics, Workflow Outlook (Revenue – USD Million, 2016 – 2028)
- 发现信息学
- 识别，验证和测定发展信息学
- 领先一代
- 开发信息学
- Lead Optimization
- FHD准备
- IA阶段
- 阶段IB / 2
药物发现信息学，模式前景（收入 - 百万，2016 - 2028）
- Outsourced
- 内部
Drug Discovery Informatics, Services Outlook (Revenue – USD Million, 2016 – 2028)
- 序列分析平台
- Molecular Modeling
- 码头
- 临床试验数据管理
- Other Services
药物发现信息学，通过区域前景（收入 - 百万，2016 - 2028）
- North America
- U.S.
- 加拿大
- 欧洲
- 法国
- 德国
- UK
- 意大利
- 西班牙
- Netherlands
- Austria
- Asia Pacific
- China
- 印度
- Japan
- 马来西亚
- South Korea
- Indonesia
- Central & South America
- 墨西哥
- 巴西
- 阿根廷
- Middle East & Africa
- UAE
- Saudi Arabia
- 以色列
- South Africa